As shown in Fig. 13A,B, the Toll-like receptor signaling pathway was negatively correlated with HS6ST2 expression in bladder urothelial carcinoma and pancreatic adenocarcinoma. Here, HS6ST2 is linked to bladder transitional cell carcinoma.